The role of galectins in colorectal cancer progression
Authors:
- 22 April 2011
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (1) , 1-8
Abstract
Galectins constitute a family of 15 mammalian galactoside‐binding proteins that share a consensus amino acid sequence in their carbohydrate binding sites. They are multi‐functional molecules and are expressed widely in human tissues. Four galectins: galectin −1, −3, −4 and −8 are expressed in the human colon and rectum and their expressions show significant changes during colorectal cancer development and metastasis. These changes in galectin expression correlate with alterations in cancer cell growth, apoptosis, cell–cell and cell–matrix interactions and angiogenesis. This review summaries current knowledge of the expression and roles of these galectins in the progression of human colorectal cancer and discusses the relevance of galectins and their ligands as potential therapeutic targets for cancer treatment.Keywords
This publication has 73 references indexed in Scilit:
- Galectin‐4 functions as a tumor suppressor of human colorectal cancerInternational Journal of Cancer, 2010
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic responseJournal of Experimental Medicine, 2010
- Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikisMolecular Cancer, 2010
- N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell DeathJournal of Biological Chemistry, 2010
- Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasisWorld Journal of Gastrointestinal Oncology, 2010
- Modified citrus pectin anti-metastatic properties: one bullet, multiple targetsCarbohydrate Research, 2009
- Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell SurfaceCancer Research, 2009
- Functions of cell surface galectin-glycoprotein latticesCurrent Opinion in Structural Biology, 2007
- Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapyProceedings of the National Academy of Sciences, 2006
- Galectin Binding to Mgat5-Modified N-Glycans Regulates Fibronectin Matrix Remodeling in Tumor CellsMolecular and Cellular Biology, 2006